Throughout the COVID-19 pandemic, public health officials have focused their response into four main areas: 1) rapid and accurate testing: 2) contact tracing systems to monitor outbreaks; 3) prevention methods, such as vaccines and 4) effective treatments to aid recovery should a person become infected. For the last year and a half, biopharmaceutical companies have been working around the clock to help develop solutions, with emphasis on the latter two: the need for preventative vaccines and effective treatments.
